The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market Update

21 Nov 2019 07:00

RNS Number : 1229U
EIH PLC
21 November 2019
 

EIH plc ("EIH" or the Company")

Market Update

 The Company has been advised by EIF's Investment Manager that the life of the Evolvence India Fund PCC ("EIF") has been extended until 31 October 2020, with the likelihood that further extensions will be required thereafter. 

 

During the extension period EIF's Investment Manager will not be charging management fees although the fund will still be incurring expenses including administrative, legal, accounting and deal costs.

 

The unaudited fair value of EIF, as disclosed in EIH's interim results for the half year ended 30 June 2019, was US$9.4 million. The Company also confirms that the expected distribution of approximately US$0.9 million from EIF, as described in the interim results, has been received and the Company currently holds US$1.37 million in net cash balances.

 

In the context of the extension of EIF's life until 31 October 2020, however, the Directors have reviewed certain underlying financial information provided to them by EIF's Investment Manager. The Directors have concluded that, while they remain confident that further realisations from EIF's underling portfolio will be achieved, there is now a higher level of uncertainty as to both the value of the remaining assets to be realised and the timing of distributions to shareholders. Moreover, the Investment Manager has indicated that certain assets are the subject of negotiations for sale at a discount to the carrying value stated in our Interim results as at 30 June 2019. 

 

The Directors intend to consult with key shareholders with a view to seeking approval for the cancellation of the admission of the Company's shares to trading on AIM. The Directors believe that:

·; There is a clear lack of liquidity in the Shares of the Company;

·; The costs associated with maintaining a listing on AIM are now disproportionate to the value provided by the listing, and the Board expects savings arising from the cancellation to amount to at least £75,000 per annum.

The Directors confirm that, following cancellation, it would continue with its stated objective to realise assets at the appropriate time and value, and to return the proceeds, less expenses, to EIH's shareholders, while at the same time managing the Company's operating costs carefully.

Further announcements will be made following the consultation with key shareholders and to detail any proposals to be presented to shareholders. Any cancellation resolution to be put to shareholders would be conditional upon the approval of not less than 75 per cent. of the votes cast by shareholders at a general meeting.

For further information, please contact:

 

EIH plc

Rhys Davies

Tel: +41 (0)796200215

 

Nplus1 Singer Advisory LLP

(Nominated Advisor)

James Maxwell

Tel: +44 (0)207 496 3000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBMBRTMBTTBLL
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.